Evidence map›Paper›PMID 39420880›Full record

ReviewArchives of endocrinology and metabolism2024

A rare diagnosis of primary fibrosarcoma of the thyroid - Case report and mini-review.

Ekin Yiğit Köroğlu, Kübra Turan, Feride Pinar Altay, Fatma Dilek Dellal Kahramanca, Aydan Kiliçarslan, Bilgehan Karadayi, Oya Topaloğlu, Reyhan Ersoy, Bekir Çakir

Abstract readCase ReportsReview
In one paragraph

Review in Archives of endocrinology and metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ekin Yiğit KöroğluAnkara Bilkent City Hospital Endocrinology and Metabolism Department Ankara Turkey Ankara Bilkent City Hospital, Endocrinology and Metabolism Department, Ankara, Turkey.ORCID https://orcid.org/0000-0003-3895-5817
Kübra TuranAnkara Bilkent City Hospital Endocrinology and Metabolism Department Ankara Turkey Ankara Bilkent City Hospital, Endocrinology and Metabolism Department, Ankara, Turkey.ORCID https://orcid.org/0000-0003-0744-7481
Feride Pinar AltayAnkara Bilkent City Hospital Endocrinology and Metabolism Department Ankara Turkey Ankara Bilkent City Hospital, Endocrinology and Metabolism Department, Ankara, Turkey.ORCID https://orcid.org/0000-0002-6790-3031
Fatma Dilek Dellal KahramancaAnkara Bilkent City Hospital Endocrinology and Metabolism Department Ankara Turkey Ankara Bilkent City Hospital, Endocrinology and Metabolism Department, Ankara, Turkey.ORCID https://orcid.org/0000-0003-0755-4543
Aydan KiliçarslanAnkara Bilkent City Hospital Medical Pathology Department Ankara Turkey Ankara Bilkent City Hospital, Medical Pathology Department, Ankara, Turkey.ORCID https://orcid.org/0000-0002-7981-4458
Bilgehan KaradayiAnkara Bilkent City Hospital Radiation Oncology Department Ankara Turkey Ankara Bilkent City Hospital, Radiation Oncology Department, Ankara, Turkey.ORCID https://orcid.org/0000-0001-6433-2475
Oya TopaloğluAnkara Yildirim Beyazit University School of Medicine Endocrinology and Metabolism Department Ankara Turkey Ankara Yildirim Beyazit University School of Medicine, Endocrinology and Metabolism Department, Ankara, Turkey.ORCID https://orcid.org/0000-0003-2501-935X
Reyhan ErsoyAnkara Yildirim Beyazit University School of Medicine Endocrinology and Metabolism Department Ankara Turkey Ankara Yildirim Beyazit University School of Medicine, Endocrinology and Metabolism Department, Ankara, Turkey.ORCID https://orcid.org/0000-0002-7437-1176
Bekir ÇakirAnkara Yildirim Beyazit University School of Medicine Endocrinology and Metabolism Department Ankara Turkey Ankara Yildirim Beyazit University School of Medicine, Endocrinology and Metabolism Department, Ankara, Turkey.ORCID https://orcid.org/0000-0001-7526-8827

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant mesenchymal thyroid tumors are one of the rarest types of thyroid cancer. Clinically, these tumors present as a rapidly growing thyroid mass. Due to their rarity and nonspecific findings, they are not the first conditions that come to mind during differential diagnosis. We report herein the case of an 87-year-old woman presenting with a rapidly growing thyroid mass in whom the differential diagnosis of anaplastic cancer was challenging. Following work up, the patient was diagnosed with primary fibrosarcoma of the thyroid, a rare type of malignant mesenchymal thyroid tumor. Because she declined surgery and her clinical condition was unsuitable for chemotherapy, she was treated with palliative radiotherapy. Primary thyroid fibrosarcoma is a rare cause of thyroid cancer and should be considered in the differential diagnosis of rapidly growing thyroid masses.

Indexed as

FibrosarcomaThyroid NeoplasmsAged, 80 and overDiagnosis, DifferentialFemaleHumansThyroid Gland

Identifiers

PMID39420880
PMCPMC11326737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.